This metabolite includes a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 around fifty% of your guardian drug. Plasma concentrations of this metabolite are roughly forty% of Those people viewed for sildenafil, so the metabolite accounts for about 20% of sildenafil's pharmacologic consequences.The drug information and